Protagenic Therapeutics Inc. Warrant, a biotechnology company, focuses on developing therapeutic solutions for mood disorders and neurodegenerative diseases. Their innovative approach combines neurotrophic factors and small molecule drugs to address the underlying causes of these conditions. With a dedicated team of scientists and a promising pipeline of candidates, Protagenic Therapeutics Inc. Warrant aims to make a significant impact in the field of mental health and neurology.
